These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22995966)

  • 1. Using structured clinical feedback to encourage alternatives to use of "P.R.N." medication in a state psychiatric hospital.
    Friedman R; Nurenberg JR; Birnbaum S; Schleifer SJ
    J Psychiatr Pract; 2012 Sep; 18(5):381-7. PubMed ID: 22995966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P.R.N. medications in child state hospital inpatients.
    Vitiello B; Ricciuti AJ; Behar D
    J Clin Psychiatry; 1987 Sep; 48(9):351-4. PubMed ID: 2887549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P.R.N. (As-needed) orders and exposure of psychiatric inpatients to unnecessary psychotropic medications.
    Thapa PB; Palmer SL; Owen RR; Huntley AL; Clardy JA; Miller LH
    Psychiatr Serv; 2003 Sep; 54(9):1282-6. PubMed ID: 12954947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration of therapeutic interventions that accompany the administration of p.r.n. ('as required') psychotropic medication within acute mental health settings: a retrospective study.
    Curtis J; Baker JA; Reid AR
    Int J Ment Health Nurs; 2007 Oct; 16(5):318-26. PubMed ID: 17845551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mental health professionals' psychotropic pro re nata (p.r.n.) medication practices in acute inpatient mental health care: a qualitative study.
    Baker JA; Lovell K; Harris N
    Gen Hosp Psychiatry; 2007; 29(2):163-8. PubMed ID: 17336666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing utilization of pro re nata ('as needed') sedation in a child and adolescent psychiatric inpatient unit.
    Dean AJ; Scott J; McDermott BM
    Aust N Z J Psychiatry; 2009 Apr; 43(4):360-5. PubMed ID: 19296292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of pro re nata medications in acute inpatient care.
    Stein-Parbury J; Reid K; Smith N; Mouhanna D; Lamont F
    Aust N Z J Psychiatry; 2008 Apr; 42(4):283-92. PubMed ID: 18330770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a state law on rates of restraint on a child and adolescent unit.
    Swett C; Michaels AS; Cole JO
    Bull Am Acad Psychiatry Law; 1989; 17(2):165-9. PubMed ID: 2758118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P.r.n. medication use in a psychiatric high-dependency unit following the introduction of a nurse-led activity programme.
    Thomas B; Jones M; Johns P; Trauer T
    Int J Ment Health Nurs; 2006 Dec; 15(4):266-71. PubMed ID: 17064323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of restraints in a psychiatric department, Frederiksberg Hospital, before and after introduction of the new psychiatric law. Restraining devices].
    Schepelern ES; Aggernaes KH; Stender AK; Raben H
    Ugeskr Laeger; 1993 Dec; 155(50):4091-5. PubMed ID: 8273229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Descriptive analysis of pro re nata medication use at a Canadian psychiatric hospital.
    Martin K; Arora V; Fischler I; Tremblay R
    Int J Ment Health Nurs; 2017 Aug; 26(4):402-408. PubMed ID: 27804222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro re nata use in a psychiatric intensive care unit.
    Mullen A; Drinkwater V
    Int J Ment Health Nurs; 2011 Dec; 20(6):409-17. PubMed ID: 21564456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotropic drugs prescription at two regional psychiatric hospitals in northern Nigeria.
    Adeponle AB; Obembe AO; Nnaji F; Adeyemi SO; Suleiman GT
    West Afr J Med; 2008 Apr; 27(2):106-10. PubMed ID: 19025025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of evidence that the pro re nata regimen confers benefit: a review of the studies.
    Yoshida K; Suzuki T; Uchida H; Mimura M
    Int Clin Psychopharmacol; 2013 Sep; 28(5):228-37. PubMed ID: 23727905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical decision-making for 'as needed' medications in mental health care.
    Usher K; Baker JA; Holmes C; Stocks B
    J Adv Nurs; 2009 May; 65(5):981-91. PubMed ID: 19291187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro re nata medication for psychiatric inpatients: time to act.
    Hilton MF; Whiteford HA
    Aust N Z J Psychiatry; 2008 Jul; 42(7):555-64. PubMed ID: 18612858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreasing the use of restraint and seclusion among psychiatric inpatients.
    Hellerstein DJ; Staub AB; Lequesne E
    J Psychiatr Pract; 2007 Sep; 13(5):308-17. PubMed ID: 17890979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encouraging alternatives to seclusion, restraint, and reliance on PRN drugs in a public psychiatric hospital.
    Donat DC
    Psychiatr Serv; 2005 Sep; 56(9):1105-8. PubMed ID: 16148325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding clinical decision making for PRN medication in mental health inpatient facilities.
    Usher K; Baker JA; Holmes CA
    J Psychiatr Ment Health Nurs; 2010 Aug; 17(6):558-64. PubMed ID: 20633084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.